Halozyme Therapeutics, Inc. (HALO)
NASDAQ: HALO · IEX Real-Time Price · USD
38.17
+0.36 (0.95%)
Apr 19, 2024, 10:43 AM EDT - Market open
Halozyme Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 - 2001 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 829.25 | 660.12 | 443.31 | 267.59 | 195.99 | 151.86 | 316.61 | 146.69 | 135.06 | 75.33 | Upgrade
|
| Revenue Growth (YoY) | 25.62% | 48.91% | 65.67% | 36.53% | 29.06% | -52.04% | 115.84% | 8.61% | 79.28% | 37.47% | Upgrade
|
| Cost of Revenue | 192.36 | 139.3 | 81.41 | 43.37 | 45.55 | 10.14 | 31.15 | 33.21 | 29.25 | 22.73 | Upgrade
|
| Gross Profit | 636.89 | 520.81 | 361.9 | 224.23 | 150.45 | 141.73 | 285.46 | 113.49 | 105.81 | 52.6 | Upgrade
|
| Selling, General & Admin | 149.18 | 143.53 | 50.32 | 45.74 | 77.25 | 60.8 | 53.82 | 45.85 | 40.03 | 35.94 | Upgrade
|
| Research & Development | 76.36 | 66.61 | 35.67 | 34.24 | 140.8 | 150.25 | 150.64 | 150.84 | 93.24 | 79.7 | Upgrade
|
| Other Operating Expenses | 73.77 | 43.15 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Operating Expenses | 299.32 | 253.28 | 86 | 79.97 | 218.06 | 211.06 | 204.46 | 196.7 | 133.26 | 115.64 | Upgrade
|
| Operating Income | 337.57 | 267.53 | 275.9 | 144.26 | -67.61 | -69.33 | 81 | -83.21 | -27.45 | -63.04 | Upgrade
|
| Interest Expense / Income | 18.76 | 16.95 | 7.53 | 20.38 | 11.63 | 18.04 | 21.98 | 19.98 | 5.2 | 5.58 | Upgrade
|
| Other Expense / Income | -29.52 | 1.67 | 19.86 | -5.43 | -6.99 | -7.58 | -2.59 | -1.33 | -0.42 | -0.24 | Upgrade
|
| Pretax Income | 348.33 | 248.92 | 248.52 | 129.3 | -72.25 | -79.79 | 61.61 | -101.86 | -32.23 | -68.38 | Upgrade
|
| Income Tax | 66.74 | 46.79 | -154.19 | 0.22 | -0.01 | 0.54 | -1.36 | 1.16 | 0 | 0 | Upgrade
|
| Net Income | 281.59 | 202.13 | 402.71 | 129.09 | -72.24 | -80.33 | 62.97 | -103.02 | -32.23 | -68.38 | Upgrade
|
| Net Income Growth | 39.31% | -49.81% | 211.97% | - | - | - | - | - | - | - | Upgrade
|
| Shares Outstanding (Basic) | 132 | 137 | 141 | 136 | 144 | 144 | 136 | 128 | 127 | 123 | Upgrade
|
| Shares Outstanding (Diluted) | 134 | 141 | 147 | 141 | 144 | 144 | 139 | 128 | 127 | 123 | Upgrade
|
| Shares Change | -4.56% | -4.22% | 3.77% | -1.99% | 0.51% | 3.26% | 8.68% | 0.99% | 3.27% | 8.76% | Upgrade
|
| EPS (Basic) | 2.13 | 1.48 | 2.86 | 0.95 | -0.50 | -0.56 | 0.46 | -0.81 | -0.25 | -0.56 | Upgrade
|
| EPS (Diluted) | 2.10 | 1.44 | 2.74 | 0.91 | -0.50 | -0.56 | 0.45 | -0.81 | -0.25 | -0.56 | Upgrade
|
| EPS Growth | 45.83% | -47.45% | 201.10% | - | - | - | - | - | - | - | Upgrade
|
| Free Cash Flow | 373.28 | 261.31 | 297.98 | 54.03 | -89.46 | -54.16 | 132.7 | -53.52 | -39.44 | -48.89 | Upgrade
|
| Free Cash Flow Per Share | 2.83 | 1.91 | 2.12 | 0.40 | -0.62 | -0.38 | 0.97 | -0.42 | -0.31 | -0.40 | Upgrade
|
| Gross Margin | 76.80% | 78.90% | 81.64% | 83.79% | 76.76% | 93.33% | 90.16% | 77.36% | 78.35% | 69.83% | Upgrade
|
| Operating Margin | 40.71% | 40.53% | 62.24% | 53.91% | -34.50% | -45.65% | 25.58% | -56.72% | -20.33% | -83.68% | Upgrade
|
| Profit Margin | 33.96% | 30.62% | 90.84% | 48.24% | -36.86% | -52.90% | 19.89% | -70.23% | -23.86% | -90.76% | Upgrade
|
| Free Cash Flow Margin | 45.01% | 39.58% | 67.22% | 20.19% | -45.65% | -35.67% | 41.91% | -36.48% | -29.20% | -64.89% | Upgrade
|
| Effective Tax Rate | 19.16% | 18.80% | -62.04% | 0.17% | - | - | -2.21% | - | - | - | Upgrade
|
| EBITDA | 451.95 | 315.51 | 259.04 | 152.96 | -56.56 | -59.36 | 85.76 | -79.47 | -25.35 | -61.03 | Upgrade
|
| EBITDA Margin | 54.50% | 47.80% | 58.43% | 57.16% | -28.86% | -39.09% | 27.09% | -54.18% | -18.77% | -81.02% | Upgrade
|
| Depreciation & Amortization | 84.86 | 49.64 | 3 | 3.28 | 4.07 | 2.39 | 2.16 | 2.41 | 1.68 | 1.76 | Upgrade
|
| EBIT | 367.09 | 265.87 | 256.04 | 149.68 | -60.62 | -61.75 | 83.59 | -81.88 | -27.03 | -62.79 | Upgrade
|
| EBIT Margin | 44.27% | 40.28% | 57.76% | 55.94% | -30.93% | -40.66% | 26.40% | -55.82% | -20.01% | -83.35% | Upgrade
|